A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/1998
12/17/1998	CA2293444A1 Oil in water vaccine compositions
12/17/1998	CA2293439A1 Ganglioside immunostimulating complexes and uses thereof
12/17/1998	CA2293363A1 Secreted proteins and polynucleotides encoding them
12/17/1998	CA2293293A1 Vaccine compositions comprising the helicobacter pylori flge polypeptide
12/17/1998	CA2292339A1 Smad6 and uses thereof
12/17/1998	CA2291338A1 Composition and method to prevent graft rejection and other counter-adaptive t lymphocyte mediated immune responses
12/16/1998	EP0884388A1 Transgenic plants containing recombinant mistletoe lectin (rML)
12/16/1998	EP0884387A2 Human 7-transmembrane receptor HLWAR77
12/16/1998	EP0884329A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
12/16/1998	EP0884308A2 A method of preparing 16-dehydro vitamin D compounds
12/16/1998	EP0884056A1 Vaccines containing a saponin and a sterol
12/16/1998	EP0883681A1 Conjugated linoleic acids for attenuating the allergic response
12/16/1998	EP0883406A1 Use of il-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular
12/16/1998	EP0883401A1 At1 receptor antagonist for the stimulation of apoptosis
12/16/1998	EP0883344A1 Therapeutic molecules generated by trans-splicing
12/16/1998	EP0762878B1 Use of a naphthalenesulfonic acid compound for inhibiting retroviral infection
12/16/1998	EP0703902B1 Process for the production of piperidine derivatives
12/16/1998	EP0610447B1 CDw52 - SPECIFIC ANTIBODY FOR TREATMENT OF T-CELL MEDIATED INFLAMMATION OF THE JOINTS
12/16/1998	CN1202200A Fas ligang fusion protein
12/16/1998	CN1202170A Quinoline derivatives as type 1V phosphodiesterase inhibitors
12/16/1998	CN1202164A Diarylalkenylamine derivatives
12/16/1998	CN1202151A Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents
12/16/1998	CN1201791A Antiallergic agent having anti-oxidant action
12/16/1998	CN1201694A Process for preparation of immune globulin for introvenous injection by dual inactivation of virus without protectives
12/16/1998	CN1041203C Preparation of pyrazolopyridine compound
12/15/1998	US5849860 Polyethylene-protein conjugates
12/15/1998	US5849799 Use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
12/15/1998	US5849797 D-β-lysylmethanediamine derivatives and preparation thereof
12/15/1998	US5849793 HIV matrix protein tyrosine position 29 pocket binders
12/15/1998	US5849777 Cell differentiation induction with mevalonate and mevalonolactone derivatives
12/15/1998	US5849756 Pharmaceutical composition and method for modulating the immune reaction
12/15/1998	US5849736 Isoxazoline and isoxazole fibrinogen receptor antagonists
12/15/1998	US5849720 Enhancement of non-specific immune defenses by administration of underivatized, aqueous soluble glucans
12/15/1998	US5849719 Method for treating allergic lung disease
12/15/1998	US5849710 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors
12/15/1998	US5849709 Saccharopeptides and derivatives thereof
12/15/1998	US5849696 Composition and method of treating hepatitis C
12/15/1998	US5849580 Nucleic acid encoding a NF-κB activation regulatory protein, IκBβ
12/15/1998	US5849556 Human growth-related CDC10 homolog
12/15/1998	US5849535 Human growth hormone variants
12/15/1998	US5849506 Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
12/15/1998	US5849297 Modified human C3 proteins
12/15/1998	US5849283 Human interleukin-6 receptor antagonists
12/15/1998	CA2163667C Imidazole lipoxygenase inhibitors
12/15/1998	CA2160462C Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists
12/15/1998	CA1340247C Choline salts of arylmethylenyl thiazolidinones and oxazolidinones
12/15/1998	CA1340233C Antigenic epitopes of immunoglobulin e present on b cell but not basophil surface
12/15/1998	CA1340183C Immunologically active whey fraction and recovery process
12/11/1998	CA2233584A1 7tm receptor hlwar77
12/11/1998	CA2230998A1 Cdna clone hapoi67 that encodes a human 7-transmembrane receptor
12/10/1998	WO1998055622A1 Preparation of glycosylated tumor necrosis factor
12/10/1998	WO1998055615A1 Apaf-1, the ced-4 human homolog, an activator of caspase-3
12/10/1998	WO1998055609A1 Inhibitors of dna immunostimulatory sequence activity
12/10/1998	WO1998055495A2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
12/10/1998	WO1998055468A1 Oxazole compounds useful as pge2 agonists and antagonists
12/10/1998	WO1998055463A1 Diphenyl-triazole derivatives and their use as anti-gestative, immuno-suppressant and anti-tumoral agents
12/10/1998	WO1998055439A1 Indane compounds and their pharmaceutical use
12/10/1998	WO1998055154A1 Radioprotectant for peptides labeled with radioisotope
12/10/1998	WO1998055127A1 Use of vitamin d compounds to prevent transplant rejection
12/10/1998	WO1998014216A3 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/10/1998	CA2292734A1 Use of vitamin d compounds to prevent transplant rejection
12/10/1998	CA2290987A1 Radioprotectant for peptides labeled with radioisotope
12/10/1998	CA2289564A1 Preparation of glycosylated tumor necrosis factor
12/09/1998	EP0882793A2 A human 7-tm receptor similar to murine frizzled-6 gene
12/09/1998	EP0882737A1 Ligated d-protein and method of indentifying compounds that modulate receptor activity
12/09/1998	EP0882451A1 Glycine for prevention or treatment of transplant rejection
12/09/1998	EP0882228A1 Methods to identify modulators of cell signaling
12/09/1998	EP0882066A1 Peptide derivatives
12/09/1998	EP0882047A1 Quinolones and their therapeutic use
12/09/1998	EP0882046A1 Quinolones and their therapeutic use
12/09/1998	EP0882044A1 1,4-dihydropyridine compounds as bradykinin antagonists
12/09/1998	EP0882038A1 Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
12/09/1998	EP0881910A1 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines
12/09/1998	EP0881906A1 Pharmaceutical composition for immunomodulation based on peptides and adjuvants
12/09/1998	EP0881886A1 Animal feed
12/09/1998	EP0689599B1 Chimeric selectins by exchange of domains - uses thereof
12/09/1998	EP0463073B1 IMMUNOGLOBULIN A1 PROTEASES (IgA1 PROTEASES), METHOD OF GENE-TECHNOLOGICALLY PRODUCING THIS TYPE OF ENZYME AND VACCINES CONTAINING THE ENZYMES AND FRAGMENTS THEREOF FOR IMMUNIZING AGAINST BACTERIAL MENINGITIS AND OTHER DISEASES CAUSED BY IgA1 PROTEASE-PRODUCING BACTERIA
12/09/1998	EP0422186B1 Use of oncostatin m for suppressing mhc antigens
12/09/1998	CN1201391A Use of flupirtin for prevention and treatment of disease which are associated with damage to haemopoietic cell system
12/09/1998	CN1201384A Aerosol compositions
12/09/1998	CN1201369A Stimulation of cell-mediated immune responses by targeted particulated genetic immunization
12/08/1998	US5847164 Method for the preparation of chromanone 7
12/08/1998	US5847135 Inhibitors of interleukin-1β converting enzyme
12/08/1998	US5847127 Process for the preparation of 2,2'-bipyrrolyl-pyrromethene (prodigiosins) derivatives
12/08/1998	US5847082 Terminal complement inhibitor fusion proteins
12/08/1998	US5847004 Method for in vivo reduction of nitric oxide levels and compositions useful therefor
12/08/1998	US5846998 Use of phosphotyrosine phosphatase inhibitors or phosphotyrosine kinase activators for controlling cellular proliferation
12/08/1998	US5846988 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
12/08/1998	US5846987 Retroviral protease inhibiting compounds
12/08/1998	US5846965 3-aza and 3-oxa piperidone tachykinin antagonists
12/08/1998	US5846947 Composition containing nucleic acids, preparation and uses
12/08/1998	US5846810 Human 26S proteasome subunit components
12/08/1998	US5846799 Human myeloperoxidase and its therapeutic application
12/08/1998	US5846755 Method for determining the therapeutic activity of metalloproteinase inhibitor compounds
12/08/1998	US5846740 Methods and kits useful for detecting autoantibody to glutamic acid decarboxylase
12/08/1998	US5846546 Preparation and use of viral vectors for mixed envelope protein immunogenic composition against human immunodeficiency viruses
12/08/1998	US5846545 Targeted delivery of cyclopropylbenzindole-containing cytotoxic drugs
12/08/1998	US5846540 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments
12/08/1998	US5846532 Method and composition for the treatment of disorders involving immunological dysfunction
12/08/1998	CA2150129C Amino-substituted pyrazoles having crf antagonistic activity

1 ... 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 ... 1172